Roche has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based testing in oncology.
Influenza is a seasonal disease. It fluctuates in a very typical manner, and probably has for centuries, but certainly for decades since it’s been monitored.